Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128995 · ClinicalTrials.gov registry record · Phase 4
Surgical or Medical Treatment
A Phase 4 study of Diabetes Mellitus, Type 2 and Pediatric Obesity, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 3
- Study locations
NCT04128995 is a Phase 4 study of Diabetes Mellitus, Type 2 and Pediatric Obesity that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 88 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04128995, a Phase 4 study of Diabetes Mellitus, Type 2 and Pediatric Obesity, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will test the hypothesis that metabolic bariatric surgery will be more effective at providing durable glycemic control and reduce co-morbidities than intensive medical therapy in youth with type 2 diabetes.
Conditions Studied
Interventions
- PROCEDURE Bariatric Surgery
- PROCEDURE Advanced Medical Therapy and Bariatric Surgery
- DRUG Advanced Medical Therapy
Study Locations (3)
Colorado
- Children's Hospital Colorado - Aurora
Illinois
- Lurie Children's Hospital - Chicago
Ohio
- Cincinnati Childrens - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2019-12-15 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04128995
The ClinicalTrials.gov registry entry for NCT04128995 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 3 interventions - of which Bariatric Surgery is the first listed.
NCT04128995 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Illinois, Ohio.
Frequently Asked Questions
What is clinical trial NCT04128995 about?
NCT04128995 is a clinical study titled "Surgical or Medical Treatment". This study will test the hypothesis that metabolic bariatric surgery will be more effective at providing durable glycemic control and reduce co-morbidities than intensive medical therapy in youth with type 2 diabetes.
What is the current status of trial NCT04128995?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2019-12-15. Estimated completion is 2026-12.
What conditions does trial NCT04128995 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Pediatric Obesity, Bariatric Surgery Candidate.
What interventions are being tested in trial NCT04128995?
The interventions under investigation include: Bariatric Surgery (PROCEDURE), Advanced Medical Therapy and Bariatric Surgery (PROCEDURE), Advanced Medical Therapy (DRUG).
Who is sponsoring clinical trial NCT04128995?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04128995 being conducted?
This trial has 3 study locations across Colorado, Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
RECRUITING · Phase 4
-
Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes
RECRUITING · Phase 4
-
Effect of Continuing Versus Holding Metformin During Hospitalizations.
RECRUITING · Phase 4
-
Afrezza® Dosing Optimization Study
COMPLETED · Phase 4
-
Effect of Thiazolidinedione Treatment Vascular Risk Markers
COMPLETED · Phase 4
-
Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.